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for allergic sensitization in adults:
Conclusions of a systematic review
and meta-analysisTo the Editor:
Allergic sensitization to aeroallergens is a common phenom-
enon and a crucial step in the development of allergic diseases.
Nonetheless, the influence of tobacco smoke exposure on the
development of allergic sensitization in adults is quite complex
and not totally understood.
Therefore, our objective was to systematically review the
existing evidence regarding this topic and to perform a meta-
analysis of the data collected from the included studies.
The search for studies that potentially matched the inclusion
criteria (for inclusion and exclusion criteria, see this article’s
Online Repository at www.jacionline.org) was performed inde-
pendently by 2 authors, in several databases (Fig 1). Discrep-
ancies were resolved through discussion with the
involvement of a third author when necessary. All data were
independently extracted by 2 review authors, who also
independently assessed the risk of bias in the included studies
considering the STrengthening the Reporting of OBservational
studies in Epidemiology (STROBE) statement for observa-
tional studies. For description of statistical methods, see this
article’s Online Repository at www.jacionline.org.FIG 1. Flowchart of the inclusion and exclusion criteria
COPD, Chronic obstructive pulmonary disease.Fig 1 represents the flowchart of the inclusion and exclusion
criteria used in the selection process. Of the 1387 retrieved
studies, 16 were included in the meta-analysis.
Regarding the random-effects’ meta-analysis for specific IgE,
6 studies with a total of 25,218 participants were included. The
random-effects estimate showed that tobacco smoke exerted a
statistically significant protective effect in the development of
allergic sensitization among smokers, when compared with never
smokers (odds ratio [OR], 0.692; 95% CI, 0.596-0.804; P < .001)
(Fig 2, A). For summary of the meta-analysis, sensitivity analysis,
and evaluation of publication bias, see this article’s Online Repos-
itory at www.jacionline.org.
Concerning the fixed-effect meta-analysis for house dust mite
(HDM)-specific IgE, 5 studies with a total of 31,782 participants
were included. The fixed-effect estimate revealed that tobacco
smoke exposure increases significantly the risk of allergic
sensitization to HDM in smokers, when compared with never
smokers (OR, 1.184; 95% CI, 1.113-1.259; P < .001) (Fig 2, B).
For summary of the meta-analysis, sensitivity analysis, and eval-
uation of publication bias, see this article’s Online Repository.
Relatively to the random-effects’ meta-analysis for skin prick
tests, 7 studies with a total of 11,041 participants were included.
The random-effects estimate revealed that tobacco smoke
exposure exerted a significant protective effect in the develop-
ment of allergic sensitization among smokers when compared
with never smokers (OR, 0.714; 95% CI, 0.596-0.856; P < .001)
(Fig 2,C). For summary of the meta-analysis, sensitivity analysis,used in this systematic review and meta-analysis.
FIG 2. A, Forest plot representing the comparison of tobacco smoke exposure on specific IgE in smokers vs
never smokers. B, Forest plot representing the comparison of tobacco smoke exposure on HDM-specific IgE
in smokers vs never smokers. C, Forest plot representing the comparison of tobacco smoke exposure on
SPTs in smokers vs never smokers. SPT, Skin prick test.
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This study revealed that, in general, smokers have a lower risk
of developing allergic sensitization to common aeroallergens,
when compared with never smokers (for IgE: OR, 0.692; 95%CI,
0.596-0.804; P < .001; for skin prick tests: OR, 0.714; 95% CI,
0.596-0.856; P < .001). These results support the hypothesis
that tobacco smoke exerts a protective effect in the development
of allergic sensitization to some aeroallergens, most likely
through its immunosuppressant effects. Chronic exposure to to-
bacco smoke affects both innate and adaptive immune responses.1
Various components of tobacco smoke were found to induce an
increase in suppressor T cells, a decrease in TH cells,
2 a significant
reduction in natural killer cells, and a decrease in serum levels of
immunoglobulins.1 Furthermore, high-dose cigarette smoke has
also been shown to directly suppress T-cell function, including
TH2-cell response, which plays an important role in IgE produc-
tion and in the development of immediate hypersensitivity.2 This
suppression in TH2-cell function might result in a lower risk of
developing allergic sensitization to certain aeroallergens. Never-
theless, the higher risk for HDM sensitization that was observed
among smokers still remains to be explained.
Regarding HDM sensitization, the observed results show that
smokers have a higher risk of developing allergic sensitization to
HDM allergens, when compared with never smokers (OR, 1.184;
95%CI, 1.113-1.259; P< .001). The differences observed may be
due to a difference in biochemical function. Almost all inhalant
allergens are proteases.3 HDM proteases other than the group 1
allergens, to which belongs the major HDM allergen Dermato-
phagoides pteronyssinus 1 (a cysteine protease), induce only
low levels of sensitization, and very few allergens from other
sources are cysteine proteases.3,4 This may be a possible explana-
tion to why tobacco smoke exposure is able to exert a protective
effect on most aeroallergens, but not on Der p 1.
Der p 1 can act as an adjuvant in the sensitization process and
elicit allergic responses both to itself and to other allergens. The 4
main mechanisms by whichDer p 1 induces allergic sensitization
are through (1) cleavage of CD235 (a low-affinity IgE Fc recep-
tor), which leads to IgE-mediated immune responses4; (2) degra-
dation and inactivation of lung surfactant proteins A and D,6
which inhibit the binding of inhalant allergens to cell-
sequestered IgE; (3) cleavage of a1-antitrypsin,7 a pulmonary
antiprotease, whose activity in smokers is already significantly
reduced; and (4) disruption of the epithelial barrier function,
which increases permeability to other allergens, facilitating their
access to dendritic cells4 and promoting the development of
allergic sensitization.
The mechanism by which tobacco smoke exerts a protective
effect on allergic sensitization to some aeroallergens, but not
others, has not yet been clarified. A study performed by
Lanckacker et al8 showed that cigarette smoke short exposure
was sufficient to promote dendritic cell–mediated transport of
HDM allergens to lymph nodes and elicit a TH2 immune
response, thus facilitating the process of allergic sensitization to
HDM allergens. Moreover, some components of tobacco smoke
may be able to alter allergenic properties of some proteins, poten-
tiating or abating their allergenic potential.9
These hypotheses may explain, at least partially, the differ-
ences observed between sensitization to HDM allergens and
sensitization to other aeroallergens. Regardless, tobacco smoke
has deeply detrimental effects in human health, and these resultssuggest that a protective effect in the development of allergic
sensitization should not be considered an argument in favor to
initiate or perpetuate this harmful habit. In the future, more
studies that illustrate the mechanism by which tobacco smokes
induces allergic sensitization to HDM and prevents sensitization
to other aeroallergens are needed, as well as enlightenment on
other factors involved in the process.
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nacionalizaç~ao (POCI) - COMPETE 2020 - Operational Program Competitiveness
and Internationalization in Axis I - Strengthening research, technological develop-
ment and innovation (Project POCI-01-0145-FEDER-007491).
Disclosure of potential conflict of interest: The authors declare that they have no relevant
conflicts of interest.
REFERENCES
1. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol
2002;2:372-7.
2. Thatcher TH, Benson RP, Phipps RP, Sime PJ. High-dose but not low-dose main-
stream cigarette smoke suppresses allergic airway inflammation by inhibiting T
cell function. Am J Physiol Lung Cell Mol Physiol 2008;295:412-21.
3. Demoly P, Hellings P, Muraro A, Papadopoulos NG, van Ree R. Global atlas of
allergy. Zurich, Switzerland: European Academy of Allergy and Clinical Immu-
nology; 2014. Available at: www.eaaci.org.
4. Bessot JC, Pauli G. Mite allergens: an overview. Eur Ann Allergy Clin Immunol
2011;43:141-56.
5. Shakib F, Schulz O, Sewell H. A mite subversive: cleavage of CD23 and CD25 by
Der p 1 enhances allergenicity. Immunol Today 1998;19:313-6.
6. Deb R, Shakib F, Reid K, Clark H. Major house dust mite allergens Dermatopha-
goides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate
lung surfactant proteins A and D. J Biol Chem 2007;282:36808-19.
7. Kalsheker NA, Deam S, Chambers L, Sreedharan S, Brocklehurst K, Lomas DA.
The house dust mite allergen Der p1 catalytically inactivates a1-antitrypsin by spe-
cific reactive centre loop cleavage: a mechanism that promotes airway inflamma-
tion and asthma. Biochem Biophys Res Commun 1996;221:59-61.
8. Lanckacker EA, Tournoy KG, Hammad H, Holtappels G, Lambrecht BN, Joos GF,
et al. Short cigarette smoke exposure facilitates sensitisation and asthma develop-
ment in mice. Eur Respir J 2013;41:1189-99.
9. Hristova M, Spiess PC, Kasahara DI, Randall MJ, Deng B, Van Der Vliet A. The
tobacco smoke component, acrolein, suppresses innate macrophage responses by
direct alkylation of c-jun N-terminal kinase. Am J Respir Cell Mol Biol 2012;
46:23-33.
Available online September 8, 2018.
http://dx.doi.org/10.1016/j.jaci.2018.07.040Lower perinatal exposure to
Proteobacteria is an independent
predictor of early childhood wheezingTo the Editor:
We postulated that perinatal risk factors for asthma would be
associated with early exposure to bacteria or bacterial products.
To evaluate this hypothesis, we assessed circulating-free bacte-
rial DNA (cfbDNA) in umbilical cord blood from mother-child
pairs (see Table E1 in this article’s Online Repository at www.
jacionline.org) from Project Viva, a longitudinal study from
birth through childhood.1 To assess cfbDNA, we used 16s
rRNA sequencing of the V1-3 region from circulating DNA
